Form 13-F position report

BIOATLA INC

Reported by SIMPLEX TRADING LLC

BCAB CUSIP 09077B104 Manager CIK 0001488542

Reported 73,901 shares, down 46,490 (38.6%) from the prior quarter.

Reported value -82.6%; share count -38.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2026
Shares 73,901 Quarter-end amount reported
Reported value $11,898 Fair value at quarter end
Consecutive quarters held 18 Through Q1 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 167000
2022-03-31 56000
2022-06-30 66000
2022-09-30 17000
2022-12-31 89000
2023-03-31 4000
2023-06-30 0
2023-09-30 63000
2023-12-31 29000
2024-03-31 148000
2024-06-30 0
2024-09-30 50000
2024-12-31 0
2025-03-31 3000
2025-06-30 5000
2025-09-30 24000
2025-12-31 68382
2026-03-31 11898
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for BIOATLA INC held by SIMPLEX TRADING LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -73,901 (-100.0%) 0 $0 2026-08-12
Q1 2026 Reduced 73,901 -46,490 (-38.6%) < 0.01% $11,898 2026-05-14
Q4 2025 Added 120,391 +84,235 (233.0%) < 0.01% $68,382 2026-02-11
Q3 2025 Added 36,156 +22,858 (171.9%) < 0.01% $24,000 2025-11-12
Q2 2025 Added 13,298 +3,835 (40.5%) < 0.01% $5,000 2025-08-05
Q1 2025 New 9,463 +9,463 (0.0%) < 0.01% $3,000 2025-05-12
Q4 2024 Reduced 0 -28,490 (-100.0%) 0 $0 2025-02-11
Q3 2024 New 28,490 +28,490 (0.0%) < 0.01% $50,000 2024-11-08
Q2 2024 Reduced 0 -43,239 (-100.0%) 0 $0 2024-07-25
Q1 2024 Added 43,239 +31,313 (262.6%) < 0.01% $148,000 2024-04-25
Q4 2023 Reduced 11,926 -25,575 (-68.2%) < 0.01% $29,000 2024-02-02
Q3 2023 New 37,501 +37,501 (0.0%) < 0.01% $63,000 2023-11-01
Q2 2023 Reduced 0 -1,858 (-100.0%) 0 $0 2023-08-04
Q1 2023 Reduced 1,858 -8,966 (-82.8%) < 0.01% $4,000 2023-04-27
Q4 2022 Added 10,824 +8,565 (379.2%) < 0.01% $89,000 2023-02-02
Q3 2022 Reduced 2,259 -21,212 (-90.4%) < 0.01% $17,000 2022-11-04
Q2 2022 Added 23,471 +12,215 (108.5%) < 0.01% $66,000 2022-08-03
Q1 2022 Added 11,256 +2,703 (31.6%) < 0.01% $56,000 2022-05-02
Q4 2021 New 8,553 +8,553 (0.0%) < 0.01% $167,000 2022-02-04

Who else reported the position

47 managers reported BIOATLA INC for Q1 2026.

Managers reporting BIOATLA INC in Q1 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ACORN CAPITAL ADVISORS LLC Added 5,406,345 +571,234 0.25% $865,015 6 qtrs
MILLENNIUM MANAGEMENT LLC Added 2,756,674 +1,994,280 < 0.01% $443,825 22 qtrs
VANGUARD CAPITAL MANAGEMENT LLC New 1,649,252 +1,649,252 < 0.01% $265,530 1 qtr
ACADIAN ASSET MANAGEMENT LLC Added 1,233,919 +476,248 < 0.01% $198,000 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 689,182 +188,854 < 0.01% $110,976 22 qtrs
DEUTSCHE BANK AG Reduced 525,352 -1 < 0.01% $84,056 21 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 510,514 -196,700 < 0.01% $82,193 18 qtrs
BlackRock Inc Reduced 480,931 -2 < 0.01% $77,430 7 qtrs
CITADEL ADVISORS LLC New 435,675 +435,675 < 0.01% $70,144 3 qtrs
UBS Group AG Added 375,569 +149,885 < 0.01% $60,466 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2026
Filed
May 14, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
73,901
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.